Concepedia

Meghan C. Thompson

MC

Statistics

Publications

29

Citations

1.6K

H-Index

17

Active since

2012

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

The Ohio State University

Kettering University

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

Meghan C. Thompson is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and chronic lymphocytic leukemia therapy.

ORCID

Publications per year

2012–2024

29

Publications

29

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 452 citations · Full text

, , +12

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

Anthony R. Mato, Meghan C. Thompson, John N. Allan et al. · Haematologica · 2018 · 165 citations · Full text

, , +17

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Skye Montoya, Jessie Bourcier, Mark Noviski et al. · Science · 2024 · 148 citations · Full text

, , +15

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

Lindsey E. Roeker, David A. Knorr, Melissa S. Pessin et al. · Leukemia · 2020 · 109 citations · Full text

, , +12

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024

William G. Wierda, Jennifer R. Brown, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2024 · 84 citations · Full text

, , +16

1–5 of 29